How do I find clinical trials in the UK?

Use TrialConnect to search by condition, location, or eligibility. We index over 29,000 UK clinical trials from ClinicalTrials.gov, updated daily. Enter your condition and we show matching trials near you.

Are there paid clinical trials in the UK?

Yes. Healthy volunteers can earn £500–£3,000 for Phase 1 and bioequivalence studies. TrialConnect lists paid research studies at UK research units in London, Leeds, Nottingham, and more.

What conditions have clinical trials available?

TrialConnect covers 41 conditions including breast cancer, lung cancer, diabetes, heart failure, COPD, multiple sclerosis, Parkinson's disease, Crohn's disease, and many more.

Is TrialConnect free?

Yes. TrialConnect is completely free for patients. We are not affiliated with the NHS or NIHR. Data is sourced from ClinicalTrials.gov.

Am I eligible for a clinical trial?

Each trial has specific eligibility criteria including age, condition, medical history, and current treatments. TrialConnect shows you trials that may match your situation, but only the trial team can confirm eligibility.

Decision Support Tool for Revascularisation Options in Coronary Artery Disease

View on ClinicalTrials.gov ↗

At a glance

What the study gets you: Health checks and monitoring — no treatment given
Type of study: Observational (no treatment given)
Time in hospital: In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention: Decision Support Tool (DECIDE-CAD) (other)
How long the study runs: Study runs about 35 months (dates as stated)
About the drug or intervention: Decision Support Tool (DECIDE-CAD) — other: DECIDE-CAD is a decision support tool - designed using mixed methods through this study - which aims to enable shared decision making with people who are considering revascularisation options for coronary artery disease.
Patient visit burden: Not specified by the sponsor

Type of study: Observing health over time
Ages: Not specified
Who: All
Number of participants: 126
Started: 2024-10-11
Last checked: 2025-03

Plain English Summary

What is this study?

• Testing a new treatment for coronary artery disease
• Clinical study - 126 participants
• Together with patients and healthcare professionals, we want to design a Decision Support Tool (DST) that will help people with coronary artery disease to understand and choose treatments that best reflect their preferences and values

Who can take part?

• Adults
• Diagnosed with coronary artery disease

Where?

• Leicester - University of Leicester
• Leicester - University Hospitals of Leicester

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

Together with patients and healthcare professionals, we want to design a Decision Support Tool (DST) that will help people with coronary artery disease to understand and choose treatments that best reflect their preferences and values. Coronary artery disease (CAD) is a leading cause of death. Blood vessels supplying oxygen to the heart muscle become narrowed by a gradual build-up of fatty material. This can result in heart attacks, heart failure, and sudden death. One way to treat the blockage is by inserting an inner sleeve called a "stent" into the blood vessel and clearing the blockage by forcing it into the artery wall. Another method involves diverting the blood supply around the blockage using a vessel harvested from another body site; this is called "bypass surgery". The best treatment, either stents or surgery, is different for everyone. A Decision Support Tool (DST) will provide key information on the pros and cons of stents or surgery and how these match an individual's preferences and values. People are then empowered to make shared decisions about treatment with their doctors. Personalising treatment decisions in this way can reduce inequalities in care and improve shared decision making. Our proposed research will develop a DST in the form of a webpage with alternative print material for those at risk of digital poverty. The DST will be developed in multiple languages to improve accessibility. There are two parts to the study: the first part will use the experience of patients, who have already had stent or surgery, and healthcare professionals to design and refine a DST prototype; this will be done through workshops, focus groups, and cognitive interviews. The second part will test whether it is possible to use the DST by people with CAD waiting for a procedure; this will be done through questionnaires and interviews. The result of this study can then subsequently inform an assessment of the refined DST on a national level, with the hopes of enabling more effective shared decision making.

Coronary Artery Disease

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search

Age· Tell us your age for better matching

Gender· Tell us your sex for better matching

Still need:

• Tell us your age for better matching
• Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

Age: Not specified
Who can join: All genders

Treatment history

Treatments you must have had:

✓ for cognitive interviews or acceptability questionnaire)

What the study is looking for

✓WP1. DST CO-DESIGN PATIENT PARTICIPANTS
✓Inclusion Criteria
✓Participants may enter the study if ALL of the following applies:
✓Any adult (≥ 18 years) with lived experience of coronary revascularisation
✓Willing and able to consent to study participation.

See the full criteria

WP1. DST CO-DESIGN PATIENT PARTICIPANTS Inclusion Criteria Participants may enter the study if ALL of the following applies: 1. Any adult (≥ 18 years) with lived experience of coronary revascularisation 2. Willing and able to consent to study participation. 3. Able to understand written and spoken English for decisional needs workshop or focus groups (NB this criterion is not required for cognitive interviews or acceptability questionnaire) Exclusion Criteria Participants may not enter the study if they are unable to provide informed consent. Individuals who participate in focus groups are ineligible for subsequent participation in cognitive interviews and acceptability questionnaires. WP1. DST CO-DESIGN HCP PARTICIPANTS Inclusion Criteria Participants may enter the study if ALL of the following applies: 1. Healthcare professional with a patient-facing clinical role which involves decision making regarding coronary revascularisation 2. Willing and able to consent to study participation. 3. Able to understand written and spoken English Exclusion Criteria Participants may not enter the study if they are unable to provide informed consent. WP2. DST FEASIBILITY PATIENT PARTICIPANTS Inclusion Criteria Participants may enter the study if ALL of the following applies: 1. Adult (≥ 18 years) awaiting coronary revascularisation 2. Has received coronary angiography for definitive diagnosis. 3. Willing and able to consent to study participation. 4. Able to understand written and spoken English, Polish, Romanian, Urdu, Panjabi, or Gujarati Exclusion Criteria Participants may not enter the trial if ANY of the following apply: 1. Where clinical consensus strongly recommends one option of revascularisation over another 2. Unable to provide informed consent 3. Unable to speak one of the aforementioned 6 languages WP2. DST FEASIBILITY HCP PARTICIPANTS Inclusion Criteria Participants may enter the study if ALL of the following applies: 1. Healthcare professional with a patient-facing clinical role which involves decision making regarding coronary revascularisation 2. Willing and able to consent to study participation. 3. Able to understand written and spoken English Exclusion Criteria Participants may not enter the study if they are unable to provide informed consent.

Where Is This Study? (2 UK sites)

University of Leicester

Leicester LE1 7RH, United Kingdom

NOT_YET_RECRUITING

Site contact (verified)

Dr Ann Cheng01162522101

University Hospitals of Leicester

Leicester LE39QP, United Kingdom

Recruiting

Site contact (verified)

Dr Ann Cheng01162522101 decidecad@leicester.ac.uk

How to Get in Touch

Dr Ann Cheng

Sponsor contact

CONTACT

0116 252 2101 decidecad@leicester.ac.uk

Data sourced from ClinicalTrials.gov · Last verified: 2025-03